SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert J. Donovan who wrote (59)6/4/1997 6:42:00 PM
From: Stratajema   of 369
 
Although I've never been an investor in URMD, I have been following the company's progress to decide if I should invest in future competitor, Rochester Medical (ROCM). I think I'll definitely avoid an investment in Rochester Medical even though ROCM's product is deemed superior to Uromed's. The major issues with these types of urological products are: availability of insurance reimbursement; expensive undertaking to convince patients to adopt these devices; the majority of these devices would be prescribed for short-term "stop gap" measures while patients undergo therapy.

However, given the small outstanding float of ROCM's shares, ROCM's stock price could see a retracement to the high teens when their device is approved. This would be an excellent exit point.

Good luck to all here. Remember, these small cap stocks bounce around a lot and so you will no doubt be offered the chance to get out above $5 once again.

- David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext